Recent news on Tegaserod Maleate

IBS drug Zelmac banned from sale in Australia  -  Apr 8, 2007
SpiritIndia,The drug tegaserod maleate, marketed under the name Zelmac, was taken off the market in the United States a few days ago.

Cumberland Pharmaceuticals Offers Alternative to Zelnorm  -  Apr 25, 2007
PharmaLive.com (press release),Zelnorm (tegaserod maleate) was approved by the Food and Drug Administration in 2004 for treatment of patients younger than 65 suffering from chronic

Marketing of Zelnorm Suspended; Drug Linked to Slight Increase in ...  -  Mar 30, 2007
Medscape (subscription)It also noted that no effect of tegaserod maleate on the coronary arteries was seen in preclinical and clinical testing. Quoted in a company press release

Sales halted for constipation drug  -  Mar 31, 2007
Brocktown News,Zelnorm, also called tegaserod maleate, is a prescription medication approved for short-term treatment of women with irritable bowel syndrome with

SFDA does not pull Novartis IBS drug from shelves despite FDA ban  -  Apr 18, 2007
Interfax.cn (subscription),Zelnorm, which is the trademark for the generic drug tegaserod maleate, is a prescription drug recommended for the short-term treatment of irritable bowel

Constipation Drug Pulled From Market  -  Mar 30, 2007
Therapeutics Daily (subscription) (press release),...and Drug Administration, said during a teleconference. Zelnorm (generic name tegaserod maleate) was first approved by the FDA in 2002 for the short-term

Novartis Suspends US Marketing and Sales of Zelnorm(R) in Response ...  -  Mar 30, 2007
Therapeutics Daily (subscription) (press release),US marketing and sales of Zelnorm(R) (tegaserod maleate), a treatment for irritable bowel syndrome (IBS) with constipation and chronic constipation.

Novartis suspends Canadian marketing and sales of Zelnorm(R) in ...  -  Mar 30, 2007
CNW Telbec (Communiqués de presse),Novartis markets the therapy under the trademark Zelnorm (tegaserod maleate) in the US, Canada, Philippines and South Africa; and as Zelmac (tegaserod) in

Suspended – sale of drug to treat IBS  -  Apr 2, 2007
Malaysia Star,The medication Zelmac (tegaserod maleate), which is marketed in the United States under the brand name Zelnorm, has been found by the Food and Drug

US Zelnorm Sales and Marketing Suspended  -  Mar 30, 2007
Facts and Comparisons,Novartis is suspending the US sales and marketing of its product Zelnorm (tegaserod maleate), indicated for irritable bowel syndrome with constipation and

Novartis Suspends US Marketing and Sales of Zelnorm in Response to ...  -  Mar 30, 2007
eMaxHealth.com,Novartis is complying with a request from the Food and Drug Administration (FDA) to suspend US marketing and sales of Zelnorm(R) (tegaserod maleate),

Novartis Suspends Sales of Zelnorm® After Request From FDA  -  Mar 30, 2007
EndoNurse,US marketing and sales of Zelnorm® (tegaserod maleate), a treatment for irritable bowel syndrome (IBS) with constipation and chronic constipation.

Constipation drug pulled off the market  -  Mar 30, 2007
Dallas Morning News (subscription),Zelnorm, also called tegaserod maleate, is approved for short-term treatment of women with irritable bowel syndrome with constipation and for patients

Novartis Pulls Constipation Drug Linked To Increased Risk Of Heart ...  -  Mar 30, 2007
All Headline NewsAccording to the FDA, patients using Zelnorm, also called tegaserod maleate, are advised to contact their health care providers to switch over to

Sales suspended for anti-constipation drug  -  Mar 30, 2007
CBC News,Novartis is stopping sales of Zelnorm, also called tegaserod maleate, in Canada and the US at the request of regulators.

Novartis shares drop after Zelnorm sales stop, profit warning  -  Apr 2, 2007
Canada.com,Zelnorm, also called tegaserod maleate, was pulled off the US market at the request of the Food and Drug Administration after being linked to increased

Novartis suspends US marketing and sales of Zelnorm  -  Apr 2, 2007
SpiritIndia,Novartis is complying with a request from the Food and Drug Administration (FDA) to suspend US marketing and sales of Zelnorm (tegaserod maleate),

Zelnorm withdrawn  -  Apr 2, 2007
Cay Compass,Zelnorm, also called tegaserod maleate, is a prescription medication approved for short–term treatment of women with irritable bowel syndrome with

Constipation Drug Pulled From Market  -  Mar 30, 2007
Atlanta Journal Constitution (subscription),Zelnorm (generic name tegaserod maleate) was first approved by the FDA in 2002 for the short-term treatment of women with irritable bowel syndrome whose

FDA Asks Swiss Pharmaceutical Company To Stop Selling Constipation ...  -  Mar 31, 2007
Free Internet Press,Zelnorm, also called tegaserod maleate, is a prescription medication approved for the short-term treatment of women with irritable bowel syndrome,

Irritable Bowel Syndrome Drug Zelnorm Taken Off Market  -  Mar 31, 2007
Toronto Daily News,Food and Drug Administration. Novartis press statement, March 30, 2007. FDA: "Public Health Advisory: Tegaserod maleate (marketed as Zelnorm)."

FDA: Zelnorm Being Pulled From Market  -  Mar 30, 2007
DG News2007 -- FDA is issuing this public health advisory to inform patients and health care professionals that the sponsor of Zelnorm (tegaserod maleate),

Zelnorm Read Before You Buy, Zelnorm Online Posted By : Quinn -  -  Feb 17, 2007
Business Portal 24 (press release),Its important to know you can find some great buys on Zelnorm {Tegaserod Maleate} at many online websites. But lately weve been seeing a growing trend by a

Novartis officials summarized the newest activities  -  Jan 11, 2007
Therapeutics Daily (subscription) (press release),Report 1: Zelnorm (tegaserod maleate) has demonstrated potential to treat the multiple symptoms of dysmotility-type dyspepsia.

AbelsonTaylor Expands DTC Capabilities  -  Nov 27, 2006
PharmaLive.com (press release),...of the most successful Rx consumer launches in history, including the Gold Effie Award-winning campaign for Zelnorm (tegaserod maleate) from Novartis.

New Data for Tegaserod maleate Demonstrate Relief of Multiple ...  Oct 24, 2006
LAS VEGAS, NV -- October 24, 2006 -- Zelnorm (tegaserod maleate) has demonstrated potential to treat the multiple symptoms of dysmotility-type dyspepsia ... -DG News Dyspepsia :: Zelnorm, tegaserod maleate for relief of multiple ...  Oct 25, 2006
The gastrointestinal medicine Zelnorm® (tegaserod maleate) has demonstrated potential benefits in helping patients with the multiple symptoms of a common ... -SpiritIndia, New Data for Zelnorm(R) Demonstrate Relief of Multiple Symptoms of ...  Oct 25, 2006
23 /PRNewswire-FirstCall/ -- Zelnorm (tegaserod maleate) has demonstrated potential to treat the multiple symptoms of dysmotility-type dyspepsia, according to ... -Drug Newswire (press release), New Data For Zelnorm(R) Demonstrate Relief Of Multiple Symptoms Of ...  Oct 24, 2006
Zelnorm (tegaserod maleate) has demonstrated potential to treat the multiple symptoms of dysmotility-type dyspepsia, according to new data being presented ... -Medical News Today (press release), New Zelnorm® data demonstrate relief of multiple symptoms of  Oct 23, 2006
Basel, October 23, 2006 - The gastrointestinal medicine Zelnorm® (tegaserod maleate) has demonstrated potential benefits in helping patients with the multiple ... -WebWire (press release), New Zelnorm(R) data demonstrate relief of multiple symptoms of ...  Oct 24, 2006
BASEL, Switzerland | Oct 23, 2006 | The gastrointestinal medicine Zelnorm® (tegaserod maleate) has demonstrated potential benefits in helping patients with ... -PipelineReview.com (press release), New Data for Zelnorm Demonstrate Relief of Multiple Symptoms of ...  Oct 23, 2006
LAS VEGAS, October 23, 2006 /PRNewswire-FirstCall/ -- Zelnorm (tegaserod maleate) has demonstrated potential to treat the multiple symptoms of dysmotility-type ... -PharmaLive.com (press release), New Data for Zelnorm® Demonstrate Relief of Multiple Symptoms of ...  Oct 24, 2006
LAS VEGAS -- Zelnorm (tegaserod maleate) has demonstrated potential to treat the multiple symptoms of dysmotility-type dyspepsia, according to new data being ... -EndoNurse, Salix Pharmaceuticals Reports American College of Gastroenterology ...  Oct 24, 2006
...non-GI conditions. Patients had failed numerous therapies including PEG solution, tegaserod maleate and lactulose. Patients were ... -Genetic Engineering News (press release), Millions Live with Painful GI Symptoms Impacting Their Lives, but ...  Oct 9, 2006
Novartis Pharmaceuticals Corporation, manufacturer of Zelnorm(R) (tegaserod maleate), is the exclusive sponsor of the ABCs of GI Relief Health Center at RealAge ... -Drug Newswire (press release), AbelsonTaylor Expands DTC Capabilities  -  Nov 27, 2006
PharmaLive.com (press release),...of the most successful Rx consumer launches in history, including the Gold Effie Award-winning campaign for Zelnorm (tegaserod maleate) from Novartis.



Axcan Pharma appoints new Senior Vice President and Chief ...  May 10, 2006
While at Novartis, Dr. LeBeaut served as a project leader on major research programs, including the development of Zelnorm® (tegaserod maleate), a drug that ... - Yahoo! News





Novartis provides update on regulatory status of Zelnorm� in ...  Mar 24, 2006
For more information, please visit http://www.novartis.com. [A] Novartis markets Zelnorm (tegaserod maleate) in the US, Canada, Philippines and South Africa ... - WebWire

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional